Robert Gatmaitan

Robert Gatmaitan is an accomplished executive specializing in global compensation, total rewards, and HR operations, currently serving as Senior Vice President, People at Structure Therapeutics since September 2023. Previously, Robert held significant leadership roles at Global Blood Therapeutics as Head of Global Total Rewards, People Analytics, & HR Operations, where GBT was acquired by Pfizer, and at Avalara as VP, Global Total Rewards and M&A. Robert's extensive experience includes a tenure at MyoKardia, which was acquired by Bristol-Myers Squibb, and a lengthy career at Sanofi, where responsibilities spanned global compensation and integration activities for multiple business units. Robert also contributed to compensation strategies at Lincoln Financial Group and ACE Group, alongside consultancy work at Hay Group. Academic credentials include a Bachelor's Degree in Finance from Drexel University.